Description
Scarletred®Vision Mobile App
The app is developed and tested in clinical trials with medical experts and allows to convert a GCP compliant process in your clinical trial and medical routine applications.
Product features:
- Free Registration
- CE class I medical device
- GCP compliant
- Multi user login
- Anonymous subject allocation
- Normalised image generation
- Easy image management
- Encrypted image transfer
- Skin imaging history
More: https://www.scarletred.com/products
Hide
Show More...
The app is developed and tested in clinical trials with medical experts and allows to convert a GCP compliant process in your clinical trial and medical routine applications.
Product features:
- Free Registration
- CE class I medical device
- GCP compliant
- Multi user login
- Anonymous subject allocation
- Normalised image generation
- Easy image management
- Encrypted image transfer
- Skin imaging history
More: https://www.scarletred.com/products
Screenshots
SCARLETRED®Vision FAQ
-
Is SCARLETRED®Vision free?
Yes, SCARLETRED®Vision is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is SCARLETRED®Vision legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does SCARLETRED®Vision cost?
SCARLETRED®Vision is free.
-
What is SCARLETRED®Vision revenue?
To get estimated revenue of SCARLETRED®Vision app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Singapore yet.
Ratings History
SCARLETRED®Vision Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
177
|
SCARLETRED®Vision Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
eKare inSight Research
Clinical Research for Wound
|
Unlock
|
Unlock
|
0
|
|
7 months ago | |
Hospital at Home Wrist-monitor
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
EDF-Guidelines
N/A
|
Unlock
|
Unlock
|
0
|
|
9 months ago | |
Eczema Manager
for Atopic Dermatitis
|
Unlock
|
Unlock
|
0
|
|
4 months ago | |
tkDerm touch
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
WounDerm
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
ESDR
ESDR Association App
|
Unlock
|
Unlock
|
0
|
|
3 months ago | |
HEINE DERManager
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
Dicompass Camera 2
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
BI 1368-0098 (Lunsayil 1)
|
Unlock
|
Unlock
|
0
|
|
1 month ago |
SCARLETRED®Vision Installs
Last 30 days
SCARLETRED®Vision Revenue
Last 30 daysSCARLETRED®Vision Revenue and Downloads
Gain valuable insights into SCARLETRED®Vision performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
SCARLETRED Holding
- Languages
- English
- Recent release
- 3.12.0 (18 hours ago )
- Released on
- Dec 28, 2019 (4 years ago )
- Also available in
- Austria, Ukraine, Poland, Japan, South Korea, Kuwait, Lebanon, North Macedonia, Mexico, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, Pakistan, India, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, United States, Vietnam, South Africa, Dominican Republic, Argentina, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Denmark, Italy, Algeria, Ecuador, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel, United Arab Emirates
- Last Updated
- 58 minutes ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.